Strati, Paolo
Neelapu, Sattva S.
Article History
First Online: 27 March 2019
Compliance with Ethical Standards
:
: Paolo Strati declares that he has no conflict of interest. Sattva S. Neelapu has received research support from Kite/Gilead, Celgene, Cellectis, Poseida, Merck, Acerta, Karus, and Bristol-Myers Squibb and has served as a consultant and advisory board member for Kite/Gilead, Celgene, Novartis, Unum Therapeutics, Pfizer, CellMedica, and Merck.
: This article does not contain any studies with human or animal subjects performed by any of the authors.